United Therapeutics Corporation to Report Second Quarter 2024 Financial Results Before the Market Opens on Wednesday, July 31, 2024Business Wire • Wednesday
Why United Therapeutics (UTHR) is a Top Growth Stock for the Long-TermZacks Investment Research • 07/17/24
Is United Therapeutics (UTHR) a Solid Growth Stock? 3 Reasons to Think "Yes"Zacks Investment Research • 07/15/24
What Makes United Therapeutics (UTHR) a Strong Momentum Stock: Buy Now?Zacks Investment Research • 07/15/24
United Therapeutics Corporation (UTHR) Hit a 52 Week High, Can the Run Continue?Zacks Investment Research • 07/15/24
Why United Therapeutics (UTHR) is a Top Value Stock for the Long-TermZacks Investment Research • 07/12/24
Why United Therapeutics (UTHR) is a Top Momentum Stock for the Long-TermZacks Investment Research • 07/11/24
United Therapeutics Corporation Announces Full Enrollment of the TETON 2 Study of Inhaled Treprostinil for the Treatment of Idiopathic Pulmonary FibrosisBusiness Wire • 07/10/24
Will United Therapeutics (UTHR) Beat Estimates Again in Its Next Earnings Report?Zacks Investment Research • 07/09/24
United Therapeutics Corporation Announces Election of Jan Malcolm to its Board of DirectorsBusiness Wire • 06/27/24
United Therapeutics Corporation to Present at the Goldman Sachs 45th Annual Global Healthcare ConferenceBusiness Wire • 06/05/24